IBIan A. Blair

Ian A. Blair

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ian A. Blair has a total of 59 co-authors. Here are the top co-authors by number of shared publications:

  • Tomoyuki Oe

    Department of Bio-analytical Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan

    8 shared publications
  • Seon Hwa Lee

    Department of Bio-analytical Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan

    5 shared publications
  • Michelle V. Williams

    Centers for Cancer Pharmacology and Excellence in Environmental Toxicology, University of Pennsylvania, 854 BRB II/III, 421 Curie Boulevard, Philadelphia, Pennsylvania 19104-6160, and Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 698 Preston Research Building, Nashville, Tennessee 37232-6838

    3 shared publications
  • Alexander S. Whitehead

    Centers for Cancer Pharmacology, Pharmacogenetics, and Excellence in Environmental Toxicology, Department of Pharmacology, and Division of Rheumatology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA

    2 shared publications
  • Bradley L. Ackermann

    Drug Disposition, Eli Lilly and Company, Greenfield, IN 46140, USA

    2 shared publications
  • Jasbir S. Arora

    Center for Cancer Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6160, USA

    2 shared publications

Latest Publications

  • Open Access

    Stable Isotope Dilution Multidimensional Liquid Chromatography-Tandem Mass Spectrometry for Pancreatic Cancer Serum Biomarker Discovery

    by Kenneth H. Yu, Colin G. Barry, David Austin, Christine M. Busch, Vineet Sangar, Anil K. Rustgi, Ian A. Blair

    A novel approach to pancreatic cancer biomarker discovery has been developed, which employs a stable isotope labeled proteome (SILAP) standard coupled with extensive multidimensional separation coupled with tandem mass spectrometry (MS/MS). Secreted proteins from CAPAN-2 human pancreatic cancer derived cells were collected after conducting stable isotope labeling by amino acids in cell culture (SILAC). The resulting SILAP standard contained <0.5% of individual unlabeled proteins. Pooled sera from patients with early stage pancreatic cancer or controls were prepared, and an equal amount of the SILAP standard was added to each sample. Proteins were separated by isoelectric focusing (IEF) prior to two-dimensional liquid chromatography (2D-LC)–MS/MS analysis. A total of 1065 proteins were identified of which 121 proteins were present at 1.5-fold or greater concentrations in the sera of patients with pancreatic cancer. ELISA validation of these findings was successfully performed for two proteins, ICAM-1 and BCAM. Results of these studies have provided proof of principle that a SILAP standard derived from the CAPAN-2 secreted proteome can be used in combination with extensive multidimensional LC-MS/MS for the identification and relative quantitation of potential biomarkers of pancreatic cancer. This technique allows for the detection of low-abundance proteins, and focuses only on biologically relevant proteins derived from pancreatic cancer cells.


  • Quantification of key red blood cell folates from subjects with defined MTHFR 677C>T genotypes using stable isotope dilution liquid chromatography/mass spectrometry

    by Yuehua Huang, Stefanie Khartulyari, Megan E. Morales, Anna Stanislawska‐Sachadyn, Joan M. Von Feldt, Alexander S. Whitehead, Ian A. Blair

    Red blood cell (RBC) folate levels are established at the time of erythropoiesis and therefore provide a surrogate biomarker for the average folate status of an individual over the preceding four months. Folates are present as folylpolyglutamates, highly polar molecules that cannot be secreted from the RBCs, and must be converted into their monoglutamate forms prior to analysis. This was accomplished using an individual's plasma pteroylpolyglutamate hydrolase by lysing the RBCs in whole blood at pH 5 in the presence of ascorbic acid. Quantitative conversion of formylated tetrahydrofolate derivatives into the stable 5,10‐methenyltetrahydrofolate (5,10‐MTHF) form was conducted at pH 1.5 in the presence of [ 13 C 5 ]‐5‐formyltetrahydrofolate. The resulting [ 13 C 5 ]‐5,10‐MTHF was then used as an internal standard for the formylated forms of tetrahydrofolate that had been converted into 5,10‐MTHF as well any 5,10‐MTHF that had been present in the original sample. A stable isotope dilution liquid chromatography‐multiple reaction monitoring/mass spectrometry method was validated and then used for the accurate and precise quantification of RBC folic acid, 5‐methyltetrahydrofolate (5‐MTHF), tetrahydrofolate (THF), and 5,10‐MTHF. The method was sensitive and robust and was used to assess the relationship between different methylenetetrahydrofolate reductase ( MTHFR ) 677C>T genotypes and RBC folate phenotypes. Four distinct RBC folate phenotypes could be identified. These were classified according to the relative amounts of individual RBC folates as type I (5‐MTHF >95%; THF 20%; 5,10‐MTHF >5%), and type IV (5‐MTHF 20%; 5,10‐MTHF >5%). Copyright © 2008 John Wiley & Sons, Ltd.


  • Determination of cellular redox status by stable isotope dilution liquid chromatography/mass spectrometry analysis of glutathione and glutathione disulfide

    by Peijuan Zhu, Tomoyuki Oe, Ian A. Blair

    Oxidation of glutathione (GSH) to glutathione disulfide (GSSG) occurs during cellular oxidative stress. The redox potential of the 2GSH/GSSG couple, which is determined by the Nernst equation, provides a means to assess cellular redox status. It is difficult to accurately quantify GSH and GSSG due to the ease with which GSH is oxidized to GSSG during sample preparation. To overcome this problem, a stable isotope dilution liquid chromatography/multiple reaction monitoring mass spectrometry (LC/MRM‐MS) method has been developed using 4‐fluoro‐7‐sulfamoylbenzofurazan (ABD‐F) derivatization. ABD‐F derivatization of the GSH thiol group was rapid, quantitative, and occurred at room temperature. The LC/MRM‐MS method, which requires no sample clean‐up, was validated within the calibration ranges of 5 to 400 nmol/mL in cell lysates for GSH and 0.5 to 40 nmol/mL in cell lysates for GSSG. Calibration curves prepared by adding known concentrations of GSH and GSSG to cell lysates were parallel to the standard curve prepared in buffers. GSH and GSSG concentrations were determined in two monocyte/macrophage RAW 267.4 cell lines with or without 15‐LOX‐1 expression (R15LO and RMock cells, respectively) after treatment with the bifunctional electrophile 4‐oxo‐2( E )‐nonenal (ONE). R15LO cells synthesized much higher concentrations of the lipid hydroperoxide, 15( S )‐hydroperoxyeicosatetraenoic acid (15‐HPETE), which undergoes homolytic decomposition to ONE. GSH was depleted by ONE treatment in both RMock and R15LO cells, leading to significant increases in their redox potentials. However, R15LO cells had higher GSH concentrations (most likely through increased GSH biosynthesis) and had increased resistance to ONE‐mediated GSH depletion than RMock cells. Consequently, R15LO cells had lower reduction potentials at all concentrations of ONE. GSSG concentrations were higher in R15LO cells after ONE treatment when compared with the ONE‐treated RMock cells. This suggests that increased expression of 15( S )‐HPETE modulates the activity of cellular GSH reductases or the transporters involved in removal of GSSG. Copyright © 2008 John Wiley & Sons, Ltd.


  • Cyclooxygenase-2-Mediated Metabolism of Arachidonic Acid to 15-Oxo-eicosatetraenoic Acid by Rat Intestinal Epithelial Cells

    by Seon Hwa Lee, Kannan Rangiah, Michelle V. Williams, Angela Y. Wehr, Raymond N. DuBois, Ian A. Blair

    Rat intestinal epithelial cells that permanently express the cyclooxygenase-2 (COX-2) gene (RIES cells) were used to investigate COX-2-mediated arachidonic acid (AA) metabolism. A targeted chiral lipidomics approach was employed to quantify AA metabolites that were secreted by the cells into the culture media. When intact RIES cells were treated with calcium ionophore A-23187 (1 µM) for 1 h, 11-(R)-hydroxyeicosatetraenoic acid (HETE) was the most abundant metabolite, followed by prostaglandin (PG) E2, 15-(S)-HETE, 15-oxo-eicosatetraenoic acid (ETE), and 15-(R)-HETE. Incubation for a further 23 h after the calcium ionophore was removed resulted in a substantial increase in PGE2 concentrations while HETE and 15-oxo-ETE concentrations decreased to almost undetectable levels. A similar metabolic profile was observed when RIES cells were treated with increasing concentrations of AA for 24 h. Incubation of the RIES cells with 10 µM AA revealed that maximal concentrations of 11-(R)-HETE, 15-(S)-HETE, and 15-oxo-ETE occurred after 10 min of incubation when the 15-(S)-HETE concentrations were approximately twice that of PGE2. There was a gradual decrease in the concentrations of HETE and 15-oxo-ETE over time, whereas PGE2 concentrations increased steadily until they reached a maximum after 24 h of incubation. The ratio of PGE2 to 15-(S)-HETE was then approximately 20:1. 15-(S)-HETE and 15-oxo-ETE concentrations declined in the cell media during prolonged incubations with pseudofirst-order rate constants of 0.0121 and 0.0073 min−1, respectively. 15-(S)-HETE was shown to undergo metabolism primarily to 15-oxo-ETE, which was further metabolized to a glutathione (GSH) adduct. The GSH adduct of 15-oxo-ETE was further metabolized in the extracellular milieu to a cysteinylglycine adduct. Thus, we have established for the first time that 15-oxo-ETE can be formed biosynthetically from AA, that 15-(S)-HETE is its immediate precursor, and that 15-oxo-ETE forms a GSH adduct. For ionophore-A-23187-stimulated cells and at early time points for AA-stimulated cells, 11-(R)-HETE was the major eicosanoid to be secreted into the media. Adding increasing concentrations of AA to cells in culture made it possible to estimate with surprising accuracy endogenous eicosanoid production using regression analyses. Thus, after 24 h in the absence of added AA, 11-(R)-HETE and 15-(R)-HETE were estimated to be present at concentrations close to the detection limit of our very sensitive assay. These data further highlight the importance of endogenous COX-2-mediated lipid peroxidation and illustrate the necessity to monitor eicosanoid formation from endogenous stores of AA in cell culture experiments.


  • Endogenous Glutathione Adducts

    by Ian A. Blair

    This review provides an overview of the formation, pharmacology, and toxicology of endogenous glutathione (GSH)-adducts with particular emphasis on GSH-adducts that arise from lipid peroxidation. GSH is the major lowmolecular- weight thiol in mammalian cells. It is involved in the formation of endogenous bioactive eicosanoids and is a source of reducing equivalents in a number of biosynthetic reactions. GSH has long been recognized to act as a co-factor in the reduction of reactive oxygen species and lipid hydroperoxides by glutathione peroxidases and glutathione-Stransferases (GSTs). It also plays an important role in the reduction of reactive intermediates derived from arylamines and in the conjugation of reactive intermediates to form S-substituted endogenous GSH-adducts through its nucleophilic cysteine sulfhydryl group. Although some reactive intermediates can form adducts directly, GST-mediated reactions generally predominate. This results in the formation of bioactive endogenous GSH-adducts derived from eicosanoids, isoprostanes, estrogens, catecholamines, and 4-hydroxy-2(E)-nonenal (HNE). Cellular oxidative stress causes increased lipid peroxidation with the concomitant formation of DNA- and protein-reactive bifunctional electrophiles. It has generally been considered that HNE is the most abundant bifunctional electrophile that is formed. Several years ago we discovered that 4-oxo-2(E)-nonenal (ONE) was also a major lipid hydroperoxide-derived bifunctional electrophile. From in vitro studies, we showed that ONE and HNE arose from the common intermediate, 4-hydroperoxy-2(E)-nonenal and also showed that ONE was formed in greater amounts than HNE. We have recently made the unexpected discovery that GSH addition to ONE leads to the formation of an unusual thiadiazabicyclo-ONE-GSH-adduct (TOG), which was characterized as (2S,7R) - 7 - [N - (carboxymethyl)carbamoyl] - 5 - oxo - 12 - pentyl - 9 - thia - 1,6 - diazabicyclo[8.2.1]trideca - 10(13), 11-diene-2- carboxylic acid. TOG is one of the most abundant GSH-adducts formed during peroxide/FeII- or FeII-mediated oxidative stress in EA.hy 926 endothelial cells. As TOG is formed from ONE, these experiments have confirmed that ONE is a major lipid hydroperoxide-derived bifunctional electrophile formed during intracellular oxidative stress. TOG represents the first member of a new class of endogenous GSH-adduct biomarkers that can be used to quantify intracellular oxidative stress. Two other members of the TOG family arise from GST-mediated GSH-adduct formation with dioxododecenoic acid and dioxooctenoic acid, bifunctional electrophiles derived from the carboxy terminus of lipid hydroperoxides. The formation of TOG and TOG-related endogenous GSH-adducts can result from free radical- as well as cyclooxygenase- and lipoxygenase-mediated pathways. Analysis of the GSH-adducts by stable isotope dilution mass spectrometry-based methodology will provide a quantitative measure of enzymatic and non-enzymatic cellular oxidative stress to complement isoprostane measurements. In future studies, it will also be important to establish the biological activity of TOG and its analogs in view of the potent activity of many other endogenous GSH-adducts such as the leukotrienes.


  • Quantification of intracellular homocysteine by stable isotope dilution liquid chromatography/tandem mass spectrometry

    by Yuehua Huang, Zhi‐Yong Lu, Karen S. Brown, Alexander S. Whitehead, Ian A. Blair

    A precise and accurate stable isotope dilution liquid chromatography/tandem mass spectrometry method for the analysis of intracellular homocysteine has been developed. An internal standard, [2H8]‐homocystine, was added to cell pellets from EA.hy 926 cells grown in culture under low and high folate concentrations. d,l‐dithiothreitol was used to reduce cellular homocystine to homocysteine. Cellular proteins were precipitated by the addition of formic acid in acetonitrile. After centrifugation, a portion of the supernatant was analyzed by liquid chromatography/tandem mass spectrometry. Using a Supelcosil cyano column with an Applied Biosystems API 4000 triple quadrupole mass spectrometer, the SRM transitions for homocysteine (m/z 136 to m/z 90) and [2H4]‐homocysteine (m/z 140 to m/z 94) were monitored. The method was validated by conducting five replicate analyses on three different days at four different concentrations (concentrations at the lower limit of quantitation and expected lower quartile, mid‐range and upper quartile). The limit of detection was 2 ng/106 EA.hy 926 cells. Using this method, the intracellular homocysteine concentration in EA.hy 926 cells ranged from 10 to 36 ng/106 cells. Copyright © 2006 John Wiley & Sons, Ltd.


  • Quantitative analysis of amyloid β peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry

    by Tomoyuki Oe, Bradley L. Ackermann, Koichi Inoue, Michael J. Berna, Carlos O. Garner, Valentina Gelfanova, Robert A. Dean, Eric R. Siemers, David M. Holtzman, Martin R. Farlow, et al.

    The 40 and 42 amino‐acid residue forms of amyloid beta (A β 1–40 and A β 1–42 ) in cerebrospinal fluid (CSF) have been proposed as potential biomarkers of Alzheimer's disease (AD). Quantitative analyses of A β peptides in CSF have relied almost exclusively on the use of immunoassay‐based assays such as the enzyme‐linked immunosorbent assay (ELISA) procedure. However, due to the ability of the A β peptides to readily self‐aggregate or bind to other proteins and glassware, such analyses are extremely challenging. Analyses are further complicated by the potential of the peptides to undergo post‐translational modifications and the possibilities for cross‐reaction in the ELISA assays with endogenous components of the CSF. An approach based on liquid chromatography/tandem mass spectrometry (LC/MS/MS) has now been developed which overcomes these methodological issues. The key steps in implementing this new approach involved immunoaffinity purification coupled with the use of [ 15 N]‐labeled A β peptides as internal standards, a basic LC mobile phase, negative ion electrospray ionization, and a basic solvent for dissolving the peptides and washing the injection needle to prevent carryover of analytes during multiple injections on the LC/MS system. The validated method had limits of quantitation of 44 fmol/mL (200 pg/mL) for A β 1–42 and 92 fmol/mL (400 pg/mL) for A β 1–40 . An excellent correlation was found between the LC/MS/MS assay and an ELISA assay for A β 1–42 in human CSF (r 2 = 0.915), although less correlation was observed for A β 1–40 (r 2 = 0.644). Mean CSF A β 1–42 concentrations for samples collected 2 weeks apart from a limited number of AD patients provided additional confidence in the reproducibility of the LC/MS/MS assay. Concentrations for duplicate samples from AD patients were slightly higher than most previously reported values (mean 1.06 ± 0.25 ng/mL; n = 7). A β 1–40 concentrations in duplicate samples obtained from AD patients were also reproducible but were found to be slightly lower than most previously reported values (mean 6.36 ± 3.07 ng/mL; n = 7). Consistent with literature reports, mean A β 1–42 concentrations were found to be lower in AD patients compared with the normal subjects (mean 1.49 ± 0.59 ng/mL; n = 7), whereas there was no difference in A β 1–40 concentrations between AD patients and normal subjects (mean 5.88 ± 3.03 ng/mL; n = 7). The accuracy and precision of the LC/MS assay mean that it will be a useful complement to existing ELISA assays for monitoring therapeutic interventions designed to modulate CSF A β 1–42 concentrations in individual AD patients. Moreover, the introduction of stable isotope labeled internal standards offers the potential to achieve a more rigorous account of the influence of methodological effects related to sample collection and processing. Copyright © 2006 John Wiley & Sons, Ltd.


  • Analysis of phosphorylation sites on focal adhesion kinase using nanospray liquid chromatography/multiple reaction monitoring mass spectrometry

    by Eugene Ciccimaro, John Hevko, Ian A. Blair

    An approach based on nanospray liquid chromatography/multiple reaction monitoring mass spectrometry (LC/MRM‐MS) was developed in order to analyze twenty‐nine phosphorylated and non‐phosphorylated tryptic peptides from focal adhesion kinase (FAK). All peptides monitored were resolved and showed excellent peak shape with the exception of one doubly phosphorylated peptide. Optimization of the LC method enabled the identification and subsequent monitoring of six important tyrosine phosphorylation sites on FAK, including phosphorylated Y 397 (pY 397 ), pY 407 , pY 576 , pY 577 , pY 861 , and pY 925 . This technique was able to identify sites of phosphorylation on FAK as well as qualitatively differentiate between autocatalytic and Src‐induced phosphorylation events. FAK was shown to have autocatalytic function, which resulted in efficient phosphorylation of Y 397 . FAK was also capable of autophosphorylation on residues Y 407 and Y 576 , though apparently less effectively than autophosphorylation at Y 397 . Src was found to phosphorylate FAK at Y 407 , Y 576 , Y 577 , and Y 861 . The presence of Src increased the abundance of pY 576 at low temperature indicating Src had particularly high kinase activity toward this residue. Furthermore, Src phosphorylated FAK at Y 577 to produce FAK bis ‐phosphorylated at Y 576 and Y 577 . In addition, six novel sites of phosphorylation (Y 148 , Y 347 , Y 441 , T 503 , S 850 , and Y 1007 ) were identified on FAK. Interestingly, Src phosphorylated FAK to form a peptide uniquely phosphorylated on Y 407 , together with substantial amounts of the bis‐ phosphorylated pY 397 pY 407 peptide. These findings will impact significantly on future studies of FAK activity since pY 397 is often used as a measure of FAK activity and Src association. Copyright © 2006 John Wiley & Sons, Ltd.


  • Synthesis of the stable isotope labeled antiviral nucleoside analog [8‐13C–7,9‐15N2]‐ganciclovir

    by Naiyu Zheng, Santosh Tilve, Tomoyuki Oe, Steven M. Albelda, Suzanne Wehrli, Ian A. Blair

    Ganciclovir, a nucleoside analog of 2′‐deoxyguanosine, is a drug used in suicide gene therapy for the treatment of mesothelioma. We required a stable isotope analog of ganciclovir for use in pharmacokinetic studies in order to monitor the systemic exposure of patients to the drug. Therefore, a facile and efficient synthesis of [8‐13C–7,9‐15N2]‐ganciclovir, was devised. The synthesis was achieved in 4 steps with 25% total yield using commercially‐available [8‐13C–7,9‐15N2]‐guanine, without the need for purification of intermediates. The key step of the synthesis involved the coupling of [8‐13C–7,9‐15N2]‐guanine with 3‐propionyloxy‐2‐propionyloxy‐methoxypropyl propionate. The latter was synthesized from a commercially available dichlorohydrin. Each step of the reaction could be easily monitored by liquid chromatography–mass spectrometry. The structure of the labeled ganciclovir was confirmed using 1H, 13C, and 15N nuclear magnetic resonance spectroscopy. Copyright © 2006 John Wiley & Sons, Ltd.